GACP Standards for Cannabis Cultivation in Europe

Good Agricultural and Collection Practices (GACP) represent the foundational quality standard for cannabis cultivation intended for pharmaceutical and medical use in Europe. Based on the European Medicines Agency (EMA) guideline on GACP for starting materials of herbal origin (EMA/HMPC/246816/2005), GACP certification ensures that cannabis is cultivated, harvested, and initially processed under controlled conditions that guarantee consistent quality, traceability, and safety of the raw plant material. GACP compliance is increasingly viewed as a prerequisite for any cannabis cultivation operation that intends to supply the European medical market. While not as capital-intensive as EU GMP certification, achieving GACP standards still requires significant investment in documentation systems, standard operating procedures, personnel training, and quality control measures. The standard covers everything from seed and propagation material selection through to post-harvest handling and storage of dried cannabis. For cultivation companies, GACP certification signals to downstream GMP manufacturers and regulators that the starting material meets pharmaceutical-grade quality expectations, enabling access to the premium medical cannabis supply chain.

The GACP framework for cannabis addresses every critical stage of the cultivation process. Seed and propagation material must be identified, authenticated, and traceable to ensure genetic consistency across production batches. Cultivation sites must be assessed for potential contamination risks from soil, water, and air sources, with documented environmental monitoring programs in place. Growing conditions — whether indoor, greenhouse, or outdoor — must be controlled and recorded, including irrigation water quality testing, fertilizer and pesticide use logs, and integrated pest management (IPM) protocols. The standard emphasizes that only plant protection products approved for use on medicinal or food-grade crops should be employed, and that residue testing must verify compliance with established maximum residue limits (MRLs). All cultivation activities must be documented in detail, creating a complete audit trail from planting through harvest.

Harvesting and post-harvest handling under GACP require strict protocols to maintain product quality and prevent contamination. Harvest timing must be determined based on validated criteria — for cannabis, this typically involves monitoring trichome maturity and cannabinoid content through periodic sampling and testing. The harvesting process itself must minimize mechanical damage and contamination, with clean equipment and trained personnel. Post-harvest processing, including drying, trimming, and initial packaging, must occur in clean, controlled environments with documented temperature and humidity parameters. Drying conditions are particularly critical for cannabis, as improper drying can promote mold growth (a major quality and safety concern) or degrade cannabinoid and terpene profiles. Storage of dried cannabis must be in suitable containers under controlled conditions, with batch-specific documentation that includes weight, moisture content, visual quality assessment, and any quality control test results.

Personnel and training requirements under GACP mandate that all staff involved in cultivation and post-harvest operations receive documented training appropriate to their roles. This includes training on hygiene practices, standard operating procedures, pest and disease identification, proper handling techniques, and quality control protocols. A designated responsible person must oversee GACP compliance and maintain the quality documentation system. Record-keeping requirements are extensive — cultivation logs, environmental monitoring data, input application records, harvest records, processing logs, and quality test results must all be maintained and available for inspection. These records must be retained for a minimum period (typically 5-10 years depending on the national authority) and must enable full traceability of any batch from finished product back to the specific cultivation lot and growing conditions.

Obtaining GACP certification involves an audit by an accredited third-party certification body or, in some cases, by the national competent authority. The audit assesses compliance with the EMA GACP guideline across all applicable areas including site suitability, cultivation practices, harvesting procedures, personnel qualifications, documentation systems, and quality control measures. Audits typically require 1-3 days on-site depending on the scale of operations. Non-conformities must be addressed through corrective actions before certification is granted. Once certified, operations are subject to annual surveillance audits to maintain their status. The cost of GACP certification — including preparation, documentation development, and the audit itself — typically ranges from 50,000 to 200,000 euros, making it significantly more accessible than GMP certification. For cannabis companies building toward full vertical integration in European medical markets, GACP certification is the logical first step before investing in GMP-level manufacturing capabilities.